Literature DB >> 8990188

Beta cell apoptosis in T cell-mediated autoimmune diabetes.

M O Kurrer1, S V Pakala, H L Hanson, J D Katz.   

Abstract

Insulin-dependent diabetes mellitus results from T cell-mediated destruction of insulin-producing, pancreatic islet beta cells. How this destruction takes place has remained elusive--largely due to the slow kinetics of disease progression. By crossing a transgenic mouse carrying a beta cell-specific T cell receptor onto the NOD.scid background, we produced a simplified but robust and accelerated model of diabetes. This mouse produces CD4+ T cells bearing transgenic T cell receptor but is devoid of CD8+ T cells and B cells. More importantly, this mouse develops a rapid diabetes, which has allowed us to record and quantify beta cell death. We have determined that beta cells within the inflamed islets die by apoptosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990188      PMCID: PMC19288          DOI: 10.1073/pnas.94.1.213

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

2.  Ultrastructural morphometry of the pancreatic -cell.

Authors:  P M Dean
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

3.  Interleukin 1 inhibits insulin secretion from isolated perifused rat islets.

Authors:  W S Zawalich; V A Diaz
Journal:  Diabetes       Date:  1986-10       Impact factor: 9.461

Review 4.  Interleukin 1 beta-mediated destruction of pancreatic beta-cells in vitro. A model of beta-cell destruction in insulin-dependent diabetes mellitus?

Authors:  S Helqvist
Journal:  Dan Med Bull       Date:  1994-04

5.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide.

Authors:  J A Corbett; J L Wang; M A Sweetland; J R Lancaster; M L McDaniel
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.

Authors:  S W Christianson; L D Shultz; E H Leiter
Journal:  Diabetes       Date:  1993-01       Impact factor: 9.461

7.  Autoimmune diabetes as a consequence of locally produced interleukin-2.

Authors:  W R Heath; J Allison; M W Hoffmann; G Schönrich; G Hämmerling; B Arnold; J F Miller
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

8.  An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1 beta.

Authors:  D L Eizirik; D E Tracey; K Bendtzen; S Sandler
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

9.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes.

Authors:  Y Higuchi; P Herrera; P Muniesa; J Huarte; D Belin; P Ohashi; P Aichele; L Orci; J D Vassalli; P Vassalli
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.

Authors:  L Wogensen; M S Lee; N Sarvetnick
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  86 in total

Review 1.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

Review 2.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

4.  The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.

Authors:  Anmar Khadra; Pere Santamaria; Leah Edelstein-Keshet
Journal:  Int Immunol       Date:  2010-05-24       Impact factor: 4.823

5.  Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Authors:  Jonathan D Katz; Jennifer K Ondr; Robert J Opoka; Zacharias Garcia; Edith M Janssen
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

6.  Unacylated as well as acylated ghrelin promotes cell survival and inhibit apoptosis in HIT-T15 pancreatic beta-cells.

Authors:  R Granata; F Settanni; L Trovato; S Destefanis; D Gallo; M Martinetti; E Ghigo; G Muccioli
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

7.  Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

Authors:  John A Gebe; Kellee A Unrath; Ben A Falk; Kouichi Ito; Li Wen; Terri L Daniels; Ake Lernmark; Gerald T Nepom
Journal:  Clin Immunol       Date:  2006-09-18       Impact factor: 3.969

8.  Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

Authors:  L-Y Khil; H-S Jun; H Kwon; J K Yoo; S Kim; A L Notkins; J-W Yoon
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

9.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

Authors:  R Eldor; A Yeffet; K Baum; V Doviner; D Amar; Y Ben-Neriah; G Christofori; A Peled; J C Carel; C Boitard; T Klein; P Serup; D L Eizirik; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-21       Impact factor: 11.205

10.  Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice.

Authors:  Ji Hoon Jeong; Sun Hwa Kim; Minhyung Lee; Won Jong Kim; Tae Gwan Park; Kyung Soo Ko; Sung Wan Kim
Journal:  J Control Release       Date:  2010-01-18       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.